10-K Filing

RICH PHARMACEUTICALS, INC. CIK: 1504389 FY 2012

Filing Information

Form Type	10-K
Accession Number	`0001255294-13-000495`
Period End Date	20130331
Filing Date	20130701
Fiscal Year	2012
Fiscal Period	FY
XBRL Instance	nepa-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 39 Income Statement 25 Cash Flow Statement 39 Stockholders Equity 10

Balance Sheet 39 line items

Line Item	Tag	Value	Unit	Period
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.59K	USD	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	2.62M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.50K	USD	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	2.62M	shares	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	2.62M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$12.50K	USD	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.59K	USD	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.58K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.70K	USD	Point-in-time
Due to Shareholder	`DueToStockholdersCurrent`	$4.00K	USD	Point-in-time
Due to Shareholder	`DueToStockholdersCurrent`	$16.82K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$7.50K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$10.58K	USD	Point-in-time
Total Liabilities	`Liabilities`	$31.02K	USD	Point-in-time
Common Stock, $.001 par value, 90,000,000 shares authorized, 2,625,000 shares issued and outstanding	`CommonStockValue`	$52.50K	USD	Point-in-time
Common Stock, $.001 par value, 90,000,000 shares authorized, 2,625,000 shares issued and outstanding	`CommonStockValue`	$2.62K	USD	Point-in-time
Common Stock, $.001 par value, 90,000,000 shares authorized, 2,625,000 shares issued and outstanding	`CommonStockValue`	$2.62K	USD	Point-in-time
Preferred Stock, $.001 par value, 10,000,000 shares authorized, -0- shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value, 10,000,000 shares authorized, -0- shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.88K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.88K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-50.58K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-81.93K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$-29.43K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$1.92K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$33.81K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$12.50K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.59K	USD	Point-in-time

Income Statement 25 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	Annual
REVENUES	`Revenues`	-	USD	11 Qtrs
REVENUES	`Revenues`	-	USD	Annual
Organization costs	`GeneralAndAdministrativeExpense`	$320.00	USD	11 Qtrs
Organization costs	`GeneralAndAdministrativeExpense`	-	USD	Annual
Organization costs	`GeneralAndAdministrativeExpense`	-	USD	Annual
Professional fees	`ProfessionalFees`	$31.89K	USD	Annual
Professional fees	`ProfessionalFees`	$81.61K	USD	11 Qtrs
Professional fees	`ProfessionalFees`	$31.35K	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$31.89K	USD	Annual
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$81.93K	USD	11 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$31.35K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-31.35K	USD	Annual
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-81.93K	USD	11 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-31.89K	USD	Annual
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	11 Qtrs
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	Annual
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	Annual
NET LOSS	`IncomeLossFromContinuingOperations`	$-31.89K	USD	Annual
NET LOSS	`IncomeLossFromContinuingOperations`	$-31.35K	USD	Annual
NET LOSS	`IncomeLossFromContinuingOperations`	$-81.93K	USD	11 Qtrs
NET LOSS PER SHARE: BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	Annual
NET LOSS PER SHARE: BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	`WeightedAverageNumberOfSharesOutstandingBasicDiluted`	2.62M	shares	Annual
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	`WeightedAverageNumberOfSharesOutstandingBasicDiluted`	2.62M	shares	Annual

Cash Flow Statement 39 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`ProfitLoss`	$-31.35K	USD	Annual
Net loss for the period	`ProfitLoss`	$-81.93K	USD	11 Qtrs
Net loss for the period	`ProfitLoss`	$-31.89K	USD	Annual
Decrease in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	Annual
Decrease in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	11 Qtrs
Decrease in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$4.00K	USD	Annual
Increase in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$120.00	USD	Annual
Increase in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$6.58K	USD	Annual
Increase in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$6.70K	USD	11 Qtrs
Net Cash Used by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-31.23K	USD	Annual
Net Cash Used by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.31K	USD	Annual
Net Cash Used by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-75.23K	USD	11 Qtrs
Increase in due to shareholder	`IncreaseDecreaseDueFromOfficersAndStockholders`	$4.00K	USD	Annual
Increase in due to shareholder	`IncreaseDecreaseDueFromOfficersAndStockholders`	$16.82K	USD	11 Qtrs
Increase in due to shareholder	`IncreaseDecreaseDueFromOfficersAndStockholders`	$12.82K	USD	Annual
Increase in due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$7.50K	USD	11 Qtrs
Increase in due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$7.50K	USD	Annual
Increase in due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	$52.50K	USD	11 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$20.32K	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$4.00K	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$76.82K	USD	11 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashPeriodIncreaseDecrease`	$-10.91K	USD	Annual
Net Increase (Decrease) in Cash and Cash Equivalents	`CashPeriodIncreaseDecrease`	$1.59K	USD	11 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashPeriodIncreaseDecrease`	$-17.31K	USD	Annual
Cash and cash equivalents, beginning of period	`Cash`	$12.50K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	$1.59K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	$29.81K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	-	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$12.50K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$1.59K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$29.81K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	-	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	Annual
Interest paid	`InterestPaid`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	-	USD	Annual

Stockholders Equity 10 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, amount	`StockholdersEquity`	$-29.43K	USD	Point-in-time
Beginning balance, amount	`StockholdersEquity`	$1.92K	USD	Point-in-time
Beginning balance, amount	`StockholdersEquity`	$33.81K	USD	Point-in-time
Issuance of common stock for cash, amount	`SharesIssuedForCashValue`	$52.50K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-18.69K	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-31.35K	USD	Annual
Net loss	`NetIncomeLoss`	$-31.89K	USD	Annual
Ending balance, amount	`StockholdersEquity`	$-29.43K	USD	Point-in-time
Ending balance, amount	`StockholdersEquity`	$1.92K	USD	Point-in-time
Ending balance, amount	`StockholdersEquity`	$33.81K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.